{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:49:33Z","timestamp":1788569373198,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","award":["C\/2020\/1528"],"award-info":[{"award-number":["C\/2020\/1528"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["AKUL15-30\/G0H1216N"],"award-info":[{"award-number":["AKUL15-30\/G0H1216N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.nucmedbio.2024.108906","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T02:48:57Z","timestamp":1710816537000},"page":"108906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging"],"prefix":"10.1016","volume":"132-133","author":[{"given":"Muriel Aline","family":"Spahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaat","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Van Loy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Sathekge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe M.","family":"Deroose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Koole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Vanduffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Annaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Bormans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Cleeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2024.108906_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-411638-2.00002-1","article-title":"The intricate role of CXCR4 in cancer","volume":"124","author":"Chatterjee","year":"2014","journal-title":"Adv Cancer Res"},{"issue":"11","key":"10.1016\/j.nucmedbio.2024.108906_bb0010","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2967\/jnumed.111.098798","article-title":"PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent","volume":"52","author":"Gourni","year":"2011","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.nucmedbio.2024.108906_bb0015","first-page":"85","article-title":"First (18)F-labeled Pentixafor-based imaging agent for PET imaging of CXCR4 expression in vivo","volume":"2","author":"Poschenrieder","year":"2016","journal-title":"Tomogr Ann Arbor Mich"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0020","doi-asserted-by":"crossref","unstructured":"H. H\u00e4nscheid et al., \u201cBiokinetics and Dosimetry of [ 177 Lu]Lu-Pentixather,\u201d J Nucl Med, vol. 63, no. 5. pp. 754\u2013760, 2022. doi:https:\/\/doi.org\/10.2967\/jnumed.121.262295.","DOI":"10.2967\/jnumed.121.262295"},{"issue":"2","key":"10.1016\/j.nucmedbio.2024.108906_bb0025","first-page":"248","article-title":"First-in-human experience of CXCR4-directed Endoradiotherapy with 177Lu- and 90Y-labeled Pentixather in advanced-stage multiple myeloma with extensive intra- and extramedullary disease","volume":"57","author":"Herrmann","year":"2016","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0030","first-page":"55","article-title":"Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography","volume":"76","author":"Sanchez-Crespo","year":"2013","journal-title":"Appl Radiat Isot Data Instrum Methods Use Agric Ind Med"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0035","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.123.265622","article-title":"18F-labeled somatostatin analogs as PET tracers for the somatostatin receptor: ready for clinical use","author":"Leupe","year":"2023","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.nucmedbio.2024.108906_bb0040","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/07366299.2019.1646982","article-title":"Separation of Radiogallium from zinc using membrane-based liquid-liquid extraction in flow: experimental and COSMO-RS studies","volume":"37","author":"Pedersen","year":"2021","journal-title":"Solvent Extraction and Ion Exchange"},{"issue":"6","key":"10.1016\/j.nucmedbio.2024.108906_bb0045","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.7150\/thno.19050","article-title":"CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed multiple myeloma","volume":"7","author":"Lapa","year":"2017","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.nucmedbio.2024.108906_bb0050","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.7150\/thno.19119","article-title":"[(177)Lu]pentixather: comprehensive preclinical characterization of a first CXCR4-directed Endoradiotherapeutic agent","volume":"7","author":"Schottelius","year":"2017","journal-title":"Theranostics"},{"issue":"5332","key":"10.1016\/j.nucmedbio.2024.108906_bb0055","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1126\/science.277.5332.1656","article-title":"A broad-Spectrum chemokine antagonist encoded by Kaposi\u2019s sarcoma-associated herpesvirus","volume":"277","author":"Kledal","year":"1997","journal-title":"Science"},{"issue":"20","key":"10.1016\/j.nucmedbio.2024.108906_bb0060","doi-asserted-by":"crossref","first-page":"17476","DOI":"10.1074\/jbc.M202063200","article-title":"Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with d-peptides derived from chemokines*","volume":"277","author":"Zhou","year":"2002","journal-title":"J Biol Chem"},{"issue":"6226","key":"10.1016\/j.nucmedbio.2024.108906_bb0065","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1126\/science.1261064","article-title":"Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine","volume":"347","author":"Qin","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.nucmedbio.2024.108906_bb0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbrc.2013.05.038","article-title":"A synthetic bivalent ligand of CXCR4 inhibits HIV infection","volume":"435","author":"Xu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"10.1016\/j.nucmedbio.2024.108906_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101619","article-title":"D-peptide-based probe for CXCR4-targeted molecular imaging and radionuclide therapy","volume":"13","author":"Luyten","year":"2021","journal-title":"Pharmaceutics"},{"issue":"36","key":"10.1016\/j.nucmedbio.2024.108906_bb0080","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1021\/bi2016712","article-title":"A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry","volume":"51","author":"Choi","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejpb.2018.06.004","article-title":"Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery","volume":"138","author":"Heon Lee","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0090","doi-asserted-by":"crossref","unstructured":"E. Coudert et al., \u201cAnnotation of biologically relevant ligands in UniProtKB using ChEBI,\u201d Bioinformatics, vol. 39, no. 1. 2023. doi:https:\/\/doi.org\/10.1093\/bioinformatics\/btac793.","DOI":"10.1101\/2022.08.19.504519"},{"issue":"47","key":"10.1016\/j.nucmedbio.2024.108906_bb0095","doi-asserted-by":"crossref","first-page":"20565","DOI":"10.1073\/pnas.1012865107","article-title":"CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells","volume":"107","author":"J\u00e4hnichen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.nucmedbio.2024.108906_bb0100","first-page":"303","article-title":"Effect of a novel orally bioavailable CXCR4 inhibitor, AMD070, on the metastasis of oral cancer cells","volume":"40","author":"Uchida","year":"2018","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.nucmedbio.2024.108906_bb0105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s42003-021-02070-9","article-title":"Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization","volume":"4","author":"J\u00f8rgensen","year":"2021","journal-title":"Commun Biol"},{"issue":"4","key":"10.1016\/j.nucmedbio.2024.108906_bb0110","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1074\/jbc.M309546200","article-title":"Molecular mechanism of AMD3100 antagonism in the CXCR4 receptor: transfer of binding site to the CXCR3 receptor","volume":"279","author":"Rosenkilde","year":"2004","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.nucmedbio.2024.108906_bb0115","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1124\/mol.108.049775","article-title":"Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors","volume":"74","author":"Wong","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0120","doi-asserted-by":"crossref","unstructured":"M. A. C. Neves, S. Sim\u00f5es, and M. L. S\u00e1 e Melo, \u201cLigand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach.,\u201d J Comput Aided Mol Des, vol. 24, no. 12, pp. 1023\u20131033, Dec. 2010, doi:https:\/\/doi.org\/10.1007\/s10822-010-9393-x.","DOI":"10.1007\/s10822-010-9393-x"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.746168","article-title":"Surfaceome proteomic of glioblastoma revealed potential targets for immunotherapy","volume":"12","author":"Rose","year":"2021","journal-title":"Front Immunol"},{"issue":"1\u20133","key":"10.1016\/j.nucmedbio.2024.108906_bb0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(02)03143-5","article-title":"Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4","volume":"527","author":"Hatse","year":"2002","journal-title":"FEBS Lett"},{"issue":"5","key":"10.1016\/j.nucmedbio.2024.108906_bb0135","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1124\/mol.108.053389","article-title":"AMD3100 is a CXCR7 ligand with allosteric agonist properties","volume":"75","author":"Kalatskaya","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"49","key":"10.1016\/j.nucmedbio.2024.108906_bb0140","doi-asserted-by":"crossref","first-page":"37939","DOI":"10.1074\/jbc.C110.147470","article-title":"The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains","volume":"285","author":"Gravel","year":"2010","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.nucmedbio.2024.108906_bb0145","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1039\/c3md00080j","article-title":"A bivalent ligand targeting the putative mu opioid receptor and chemokine receptor CCR5 heterodimers: binding affinity versus functional activities","volume":"4","author":"Yuan","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0150","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejmech.2012.02.041","article-title":"Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonists","volume":"51","author":"Wijtmans","year":"2012","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.nucmedbio.2024.108906_bb0155","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/cts.12774","article-title":"Effect of rifampin-mediated OATP1B1 and OATP1B3 transporter inhibition on the pharmacokinetics of the P2Y12 receptor antagonist Selatogrel","volume":"13","author":"Schilling","year":"2020","journal-title":"Clin Transl Sci"},{"issue":"3","key":"10.1016\/j.nucmedbio.2024.108906_bb0160","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0165","doi-asserted-by":"crossref","first-page":"vdac166","DOI":"10.1093\/noajnl\/vdac166","article-title":"Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue","volume":"4, no. 1","author":"Cooper","year":"2022","journal-title":"Neuro-Oncol Adv"},{"issue":"6","key":"10.1016\/j.nucmedbio.2024.108906_bb0170","doi-asserted-by":"crossref","first-page":"618","DOI":"10.7150\/thno.11251","article-title":"Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging","volume":"5","author":"Wester","year":"2015","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.nucmedbio.2024.108906_bb0175","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.chembiol.2020.06.006","article-title":"Monitoring allosteric interactions with CXCR4 using NanoBiT conjugated Nanobodies","volume":"27","author":"Soave","year":"2020","journal-title":"Cell Chem Biol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2024.108906_bb0180","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41181-019-0084-1","article-title":"Automated GMP compliant production of [18F]AlF-NOTA-octreotide","volume":"5","author":"Tshibangu","year":"2020","journal-title":"EJNMMI Radiopharm Chem"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpba.2015.04.009","article-title":"Retention of [(18)F]fluoride on reversed phase HPLC columns","volume":"111","author":"Ory","year":"2015","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"10.1016\/j.nucmedbio.2024.108906_bb0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.nucmedbio.2013.09.002","article-title":"Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2","volume":"41","author":"Martin","year":"2014","journal-title":"Nucl Med Biol"},{"issue":"10","key":"10.1016\/j.nucmedbio.2024.108906_bb0195","doi-asserted-by":"crossref","first-page":"7478","DOI":"10.1128\/jvi.71.10.7478-7487.1997","article-title":"Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype","volume":"71","author":"Bj\u00f6rndal","year":"1997","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.nucmedbio.2024.108906_bb0200","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/JVI.72.5.4032-4037.1998","article-title":"T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use","volume":"72","author":"Schols","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0205","doi-asserted-by":"crossref","unstructured":"T. D'huys, S. Claes, T. Van Loy, and D. Schols, \u201cCXCR7\/ACKR3-targeting ligands interfere with X7 HIV-1 and HIV-2 entry and replication in human host cells,\u201d Heliyon, vol. 4, no. 3. p. e00557, 2018. doi:https:\/\/doi.org\/10.1016\/j.heliyon.2018.e00557.","DOI":"10.1016\/j.heliyon.2018.e00557"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-4690-1-2","article-title":"Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists","volume":"1","author":"Princen","year":"2004","journal-title":"Retrovirology"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.855653","article-title":"A set of experimentally validated decoys for the human CC chemokine receptor 7 (CCR7) obtained by virtual screening","volume":"13","author":"Proj","year":"2022","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.nucmedbio.2024.108906_bb0220","article-title":"The ARRIVE guidelines 2.0: updated guidelines for reporting animal research","volume":"18","author":"Percie du Sert","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.nucmedbio.2024.108906_bb0225","doi-asserted-by":"crossref","unstructured":"G. Schoofs, A. Van Hout, T. D'huys, D. Schols, and T. Van Loy, \u201cA flow cytometry-based assay to identify compounds that disrupt binding of fluorescently-labeled CXC chemokine ligand 12 to CXC chemokine receptor 4,\u201d J Vis Exp, no. 133. 2018. doi:https:\/\/doi.org\/10.3791\/57271.","DOI":"10.3791\/57271"},{"issue":"11","key":"10.1016\/j.nucmedbio.2024.108906_bb0230","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1002\/jps.22694","article-title":"Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3","volume":"100","author":"De Bruyn","year":"2011","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.nucmedbio.2024.108906_bb0235","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nprot.2012.053","article-title":"Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection","volume":"7","author":"Fridman","year":"2012","journal-title":"Nat Protoc"},{"issue":"5","key":"10.1016\/j.nucmedbio.2024.108906_bb0240","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1109\/TNS.2013.2275994","article-title":"Iterative CT reconstruction using Shearlet-based regularization","volume":"60","author":"Vandeghinste","year":"2013","journal-title":"IEEE Trans Nucl Sci"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T20:39:20Z","timestamp":1716669560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805124000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":48,"alternative-id":["S0969805124000325"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108906","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second generation Al18F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108906"}}